Furthermore, in a subtype analysis of basal-like breast cancer, which includes a majority of TNBCs, we found that neither IGF1R nor IR were associated with a worse outcome (overall survival, relapse free survival or distant disease free survival) using in-silico analysis. This evidence concerns the gene IGF1R and breast carcinoma.